The first 3 clusters, corresponding to non-small cell lung cancer, pancreatic cancer, and colorectal cancer, indicate that the bulk of research involving KRAS mutations centers on these 3 tumor types. This evidence concerns the gene KRAS and non-small cell lung carcinoma.